Contracts Finder

NHS South of England Branded Medicines - Tranche A - September 2023

NHS England

Awarded
goods
SME-friendly
Framework agreement

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.

Key details

Contracting authority
NHS England
nhs
Region
Runcorn
Delivery: United Kingdom
Sector
Healthcare & Medical
Contract value
£249,832,000ex VAT
Submissions closed
11 April 2023
Published
6 March 2023

Procurement

Contract period
1 September 2023 - 31 August 2025
2 years
Procedure type
Open procedure (above threshold)
CPV classifications
  • 33600000 Pharmaceutical products

What happened

NHS England awarded this contract to Orifarm UK | Celltrion Healthcare United Kingdom Limited | Sandoz Ltd | Amgen Ltd | GlaxoSmithKline UK Limited | Thornton and Ross Ltd | Sun Pharma UK Ltd | Accord-UK Ltd | Roche Products Ltd | Merck Sharpe & Dohme (UK) Limited | Teva UK Limited | AstraZeneca | Zentiva Pharma UK Ltd | Abbvie Ltd | Pharmacosmos UK Ltd | Pfizer Ltd | Aventis Pharma ltd t/a Sanofi | Janssen-Cilag Ltd | Eli Lilly & Company Ltd | Takeda UK Ltd | Merck Serono Limited | Organon Pharmaceuticals UK Ltd | Vifor Pharma UK Ltd | Almirall | Gedeon Richter UK Ltd | Galapagos Biotech Ltd | Chugai Pharma UK Ltd | Novo Nordisk | Novartis Pharmaceuticals UK Ltd | Merz | Sobi (Swedish Orphan Biovitrum Ltd) | UCB Pharma Ltd (primary) | Napp Pharmaceuticals Ltd worth £249,832,000 on 18 Jul 2023. The contract runs until 31 Aug 2025.

Description

NHS South of England Branded Medicines - Tranche A - September 2023

Offer reference number: CM/PHR/22/5676

CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Awarded suppliers (33)

Suppliers
  • Orifarm UK
  • Celltrion Healthcare United Kingdom Limited
  • Sandoz Ltd
  • Amgen Ltd
  • GlaxoSmithKline UK Limited
  • Thornton and Ross Ltd
  • Sun Pharma UK Ltd
  • Accord-UK Ltd
  • Roche Products Ltd
  • Merck Sharpe & Dohme (UK) Limited
  • Teva UK Limited
  • AstraZeneca
  • Zentiva Pharma UK Ltd
  • Abbvie Ltd
  • Pharmacosmos UK Ltd
  • Pfizer Ltd
  • Aventis Pharma ltd t/a Sanofi
  • Janssen-Cilag Ltd
  • Eli Lilly & Company Ltd
  • Takeda UK Ltd
  • Merck Serono Limited
  • Organon Pharmaceuticals UK Ltd
  • Vifor Pharma UK Ltd
  • Almirall
  • Gedeon Richter UK Ltd
  • Galapagos Biotech Ltd
  • Chugai Pharma UK Ltd
  • Novo Nordisk
  • Novartis Pharmaceuticals UK Ltd
  • Merz
  • Sobi (Swedish Orphan Biovitrum Ltd)
  • UCB Pharma Ltd (primary)
  • Napp Pharmaceuticals Ltd
Award value
£249,832,000
Award date
18 July 2023

Contact

Address
2nd Floor Rutland House, Runcorn, WA7 2ES
Website
https://health-family.force.com/s/Welcome
Contact name
Collette Patrick
Email
[email protected]

Identifiers

Buyer reference
CF-1622000D0O000000rwimUAA
Notice ID
7c3db894-9ea9-4129-96a0-04e021bbaf54-671788
OCID
ocds-b5fd17-47d90e8b-f08c-43df-8fe9-14b131b9338b

Explore related tenders

Other tenders from NHS England

View all →
Secondary Care Medicines Data Pre-Market Engagement£6,750,000
Quality Assurance & Improvement of Structured Learning Placement (SLP) Modules£98,000
Targeted Prostate Cancer Screening Programme - MRI Reporting Service
Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service
Strengthening Cultural Capability and Trauma Informed Care in Women’s Health£175,000

External ID: cf-ocds-b5fd17-47d90e8b-f08c-43df-8fe9-14b131b9338b • Added 4 October 2026